# Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy

> **NCT03851562** · PHASE2 · UNKNOWN · sponsor: **Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia** · enrollment: 24 (estimated)

## Conditions studied

- Ischemic Optic Neuropathy

## Interventions

- **DRUG:** Alprostadil 20 micrograms
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03851562
- **Lead sponsor:** Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-13
- **Primary completion:** 2019-06-13
- **Final completion:** 2019-10-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03851562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03851562, "Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03851562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*